Cow Interferon Beta (IFNB) Protein

Este producto es parte de IFNB1 - interferon beta 1
Product Graph
338€ (5 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Cow Interferon Beta (IFNB) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx670141
tested applications
ELISA, WB

Description

Cow Interferon Beta (IFNB) Protein is a Recombinant protein expressed in Pichia pastoris.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Interferon Beta (IFNB)
Host
Yeast
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Origin
Cow
Conjugation
Unconjugated
Size 1
5 µg
Form
Lyophilized 
Tested Applications
ELISA, WB
Buffer
Prior to lyophilization: Phosphate buffered saline
Availability
Shipped within 3-7 working days.
Storage
Store at 4 °C for up to one week. For long-term storage, store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
IFB,IFF,IFNB,IFN-beta,IFN-beta 1,Fibroblast interferon 1,IFNB1
Background
Protein IFNB1
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Interferon Beta 1 (IFNB1) is a type I interferon with a critical role in antiviral defense and immunoregulation. Produced predominantly by fibroblasts, epithelial cells, and macrophages, IFNB1 is rapidly secreted in response to viral infections and pathogen-associated molecular patterns (PAMPs) recognized by pattern recognition receptors, such as Toll-like receptors (TLRs). Upon secretion, IFNB1 binds to the interferon alpha/beta receptor (IFNAR), triggering the JAK-STAT signaling pathway. This leads to the transcription of interferon-stimulated genes (ISGs), which orchestrate antiviral responses, including the inhibition of viral replication, degradation of viral RNA, and promotion of apoptosis in infected cells. IFNB1 also enhances antigen presentation by upregulating major histocompatibility complex (MHC) class I molecules and bolsters the activation and proliferation of natural killer (NK) cells and cytotoxic T lymphocytes. Clinically, recombinant forms of IFNB1 are widely used in the treatment of multiple sclerosis (MS), where they modulate the inflammatory response and reduce disease progression. Its role in other autoimmune and infectious diseases continues to be an area of active research.

Related Products

ECA0124

Canine IFN-β (Interferon beta) ELISA Kit

Ver Producto
ECH0025

Chicken IFN-β (Interferon Beta) ELISA Kit

Ver Producto
EH0485

Human IFN-β (Interferon beta) ELISA Kit

Ver Producto